UPDATE: SVB Leerink Assumes Abbvie (ABBV) at Underperform, 'No Spending Relief During Humira Storm'
Tweet Send to a Friend
(Updated - May 23, 2022 3:40 AM EDT)
SVB Leerink analyst Andrew Berens assumes coverage on Abbvie (NYSE: ABBV) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
SVB Leerink analyst Andrew Berens assumes coverage on Abbvie (NYSE: ABBV) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
